The move is part of the new global strategy, adopted by all member countries of the World Health Organization, to fight drug-resistant diseases.
While WHO will assess implementation of the strategy at its ongoing South East Asia Regional Committee meeting in Timor Leste, India is so far ahead of the May 2017 deadline set up at the World Health Assembly meeting of WHO in Geneva in May, officials said. The resolution passed at the Assembly, which is the highest decision making body of the UN agency, asked countries to frame plans by May 2017 and align them with WHO's global strategy.
The government may soon issue restrictions on prescription and sale of commonly used antibiotics in an attempt to avoid development of drug resistance to infectious diseases like tuberculosis, malaria, urinary tract infection and even HIV.
The guidelines, part of a national action plan on anti-microbial resistance, will present a blueprint with specific norms for doctors, chemists and patients.
While all countries are struggling with the problem of rising drug resistance, India is primarily coping with antibiotics resistance which is posing an increasing threat to treating infectious diseases, as well as undermining many other advances in medicine.
Currently, over 700,000 deaths each year are attributed to drug resistance. In India, an additional two million lives can be lost by 2050 due to drug resistance.
While WHO will assess implementation of the strategy at its ongoing South East Asia Regional Committee meeting in Timor Leste, India is so far ahead of the May 2017 deadline set up at the World Health Assembly meeting of WHO in Geneva in May, officials said. The resolution passed at the Assembly, which is the highest decision making body of the UN agency, asked countries to frame plans by May 2017 and align them with WHO's global strategy.
The government may soon issue restrictions on prescription and sale of commonly used antibiotics in an attempt to avoid development of drug resistance to infectious diseases like tuberculosis, malaria, urinary tract infection and even HIV.
The guidelines, part of a national action plan on anti-microbial resistance, will present a blueprint with specific norms for doctors, chemists and patients.
While all countries are struggling with the problem of rising drug resistance, India is primarily coping with antibiotics resistance which is posing an increasing threat to treating infectious diseases, as well as undermining many other advances in medicine.
Currently, over 700,000 deaths each year are attributed to drug resistance. In India, an additional two million lives can be lost by 2050 due to drug resistance.
